Stockreport

Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF This compares to loss of $0.80 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -2%. [Read more]